Stock AMV AMERICAN VIETNAMESE BIOTECH INCORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Company American Vietnamese Biotech Incorporation

Equities

AMV

VN000000AMV5

Pharmaceuticals

End-of-day quote HANOI S.E.
Other stock markets
 23:00:00 02/05/2024 BST 		5-day change 1st Jan Change
3,200 VND 0.00% Intraday chart for American Vietnamese Biotech Incorporation +3.23% -17.95%
02-01 American Vietnamese Biotech Incorporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
02-01 American Vietnamese Biotech Incorporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Business Summary

American Vietnamese Biotech Incorporation (AmviBiotech) is a Vietnam-based company engaged in the pharmaceutical industry. The Company is involved in the manufacture of medicines, vaccines and biological products. It is also involved in the manufacture of rapid diagnostic tests and ELISA kits, as well as the trading of other medical equipment and tools. In addition, the Company is active in the manufacture of cosmetic, soaps, detergents and other polishing and cleaning products. Its other activities include real estate trading, financial investment and the manufacture of plastic products. As of December 31, 2012, the Company had one wholly owned subsidiary named American - Vietnamese Biology Company Limited.

Sales per Business

VND in Million2021Weight2022Weight Delta
Medical Equipment and Medical Laboratory Chemicals
90.9 %
140,761 63.9 % 258,912 90.9 % +83.94%
Services
6.7 %
- - 18,992 6.7 % -
Other
2.4 %
61,908 28.1 % 6,940 2.4 % -88.79%

Sales per region

VND in Million2021Weight2022Weight Delta
Vietnam
100.0 %
220,413 100.0 % 284,845 100.0 % +29.23%

Managers

Managers TitleAgeSince
Thi Nuong Dang CEO
 Chief Executive Officer 68 -
Hien Mieu Phung CTO
 Chief Tech/Sci/R&D Officer - -
Viet Ha Thi Le AUD
 Comptroller/Controller/Auditor - 17/02/20
Nga Thi Nguyen PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Thi Nuong Dang CEO
 Chief Executive Officer 68 -
Yoshitaka Nakatani CHM
 Chairman 60 28/06/18
Nguyen Khanh Le BRD
 Director/Board Member - 29/06/20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 131,105,650 97,650,186 ( 74.48 %) 0 74.48 %

Company contact information

American Vietnamese Biotech, Inc.

1/F, B10, No. 79/3 Hoang Van Thai Tan Phu Ward, District 7

70000, Ho Chi Minh City

+

http://amvibiotech.com
address American Vietnamese Biotech Incorporation(AMV)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
AMERICAN VIETNAMESE BIOTECH INCORPORATION Stock American Vietnamese Biotech Incorporation
-17.95% 16.57M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.65% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 194B
AMGEN INC. Stock Amgen Inc.
+8.08% 167B
PFIZER, INC. Stock Pfizer, Inc.
-3.40% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. AMV Stock
  4. Company American Vietnamese Biotech Incorporation